Resolvin D1 protects mice from LPS-induced acute lung injury

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 4, 2011, Pages 434-441

  Wang, Bin ^a   Gong, Xia ^a   Wan, Jing yuan ^a   Zhang, Li ^a   Zhang, Zhuo ^a   Li, Hong zhong ^a   Min, Su ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

A lipoxin A4 receptor; Acute lung injury; Lipopolysaccharide; Resolvin D1

Indexed keywords

CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; FORMYLPEPTIDE RECEPTOR LIKE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADHESION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LUNG LAVAGE; MALE; MONONUCLEAR CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR NECROSIS;

ACUTE LUNG INJURY; ANIMALS; CELL ADHESION MOLECULES; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; LUNG; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE;

EID: 79956160340     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.04.001     Document Type: Article

References (50)

1. Yang J., Qu J.M., Summah H., Zhang J., Zhu Y.G., Jiang H.N. Protective effects of imipramine in murine endotoxin-induced acute lung injury. Eur J Pharmacol 2010, 638:128-133.
2. Zhang H.Q., Wang H.D., Lu D.X., Qi R.B., Wang Y.P., Yan Y.X., et al. Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. Shock 2008, 29:617-622.
3. Matthay M.A., Zemans R.L. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011, 6:147-163.
4. Goss C.H., Brower R.G., Hudson L.D., Rubenfeld G.D. Incidence of acute lung injury in the United States. Crit Care Med 2003, 31:1607-1611.
5. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693.
6. Moon C., Han J.R., Park H.J., Hah J.S., Kang J.L. Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res 2009, 10:18.
7. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 1989, 320:365-376.
8. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349.
9. Seki H., Fukunaga K., Arita M., Arai H., Nakanishi H., Taguchi R., et al. The anti-inflammatory and proresolving mediator resolvin E1 p.otects mice from bacterial pneumonia and acute lung injury. J Immunol 2010, 184:836-843.
10. Calder P.C., Albers R., Antoine J.M., Blum S., Bourdet-Sicard R., Ferns G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009, 101(Suppl. 1):S1-S45.
11. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196:1025-1037.
12. Hong S., Gronert K., Devchand P.R., Moussignac R.L., Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 2003, 278:14677-14687.
13. Sun Y.P., Oh S.F., Uddin J., Yang R., Gotlinger K., Campbell E., et al. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 2007, 282:9323-9334.
14. Kasuga K., Yang R., Porter T.F., Agrawal N., Petasis N.A., Irimia D., et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol 2008, 181:8677-8687.
15. Krishnamoorthy S., Recchiuti A., Chiang N., Yacoubian S., Lee C.H., Yang R., et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA 2010, 107:1660-1665.
16. Duffield J.S., Hong S., Vaidya V.S., Lu Y., Fredman G., Serhan C.N., et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006, 177:5902-5911.
17. Merched A.J., Ko K., Gotlinger K.H., Serhan C.N., Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. Faseb J 2008, 22:3595-3606.
18. Jin Y., Arita M., Zhang Q., Saban D.R., Chauhan S.K., Chiang N., et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci 2009, 50:4743-4752.
19. Tiesset H., Pierre M., Desseyn J.L., Guery B., Beermann C., Galabert C., et al. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J Nutr 2009, 139:82-89.
20. Mayer K., Kiessling A., Ott J., Schaefer M.B., Hecker M., Henneke I., et al. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am J Respir Crit Care Med 2009, 179:474-483.
21. Russo T.A., Bartholomew L.A., Davidson B.A., Helinski J.D., Carlino U.B., Knight P.R., et al. Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 2002, 283:L655-L663.
22. Takano H., Inoue K., Yanagisawa R., Sato M., Shimada A., Morita T., et al. Protective role of metallothionein in acute lung injury induced by bacterial endotoxin. Thorax 2004, 59:1057-1062.
23. Kyriakides C., Jasleen J., Wang Y., Moore F.D., Ashley S.W., Hechtman H.B. Neutrophils, not complement, mediate the mortality of experimental hemorrhagic pancreatitis. Pancreas 2001, 22:40-46.
24. Ohira H., Abe K., Yokokawa J., Takiguchi J., Rai T., Shishido S., et al. Adhesion molecules and CXC chemokines in endotoxin-induced liver injury. Fukushima J Med Sci 2003, 49:1-13.
25. Steeber D.A., Tedder T.F. Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation. Immunol Res 2000, 22:299-317.
26. Azuma A., Li Y., Usuki J., Aoyama A., Enomoto T., Kudoh S. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule-1 messenger RNA induction preventing neutrophil-induced lung injury and fibrosis in bleomycin-challenged mice. Chest 2001, 120:20S-22S.
27. Kalogeris T.J., Laroux F.S., Cockrell A., Ichikawa H., Okayama N., Phifer T.J., et al. Effect of selective proteasome inhibitors on TNF-induced activation of primary and transformed endothelial cells. Am J Physiol 1999, 276:C856-C864.
28. Read M.A., Neish A.S., Luscinskas F.W., Palombella V.J., Maniatis T., Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995, 2:493-506.
29. Bradley P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78:206-209.
30. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-1350.
31. Sun J., Yang D., Li S., Xu Z., Wang X., Bai C. Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats. Eur Respir J 2009, 33:398-404.
32. Goldring S.R., Goldring M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004, S27-S36.
33. Mastbergen S.C., Lafeber F.P., Bijlsma J.W. Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology (Oxford) 2002, 41:801-808.
34. Jakubowski A., Maksimovich N., Olszanecki R., Gebska A., Gasser H., Podesser B.K., et al. S-nitroso human serum albumin given after LPS challenge reduces acute lung injury and prolongs survival in a rat model of endotoxemia. Naunyn Schmiedebergs Arch Pharmacol 2009, 379:281-290.
35. Donnelly L.E., Barnes P.J. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. Am J Respir Cell Mol Biol 2002, 26:144-151.
36. Hickey M.J., Sihota E., Amrani A., Santamaria P., Zbytnuik L.D., Ng E.S., et al. Inducible nitric oxide synthase (iNOS) in endotoxemia: chimeric mice reveal different cellular sources in various tissues. Faseb J 2002, 16:1141-1143.
37. Lo H.P., Ackland-Berglund C.E., Pritchard K.A., Guice K.S., Oldham K.T. Attenuated expression of inducible nitric oxide synthase in lung microvascular endothelial cells is associated with an increase in ICAM-1 expression. J Pediatr Surg 2001, 36:1136-1142.
38. Suresh V., Mih J.D., George S.C. Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2007, 37:97-104.
39. Erbuyun K., Vatansever S., Tok D., Ok G., Turkoz E., Aydede H., et al. Effects of levosimendan and dobutamine on experimental acute lung injury in rats. Acta Histochem 2009, 111:404-414.
40. Szczepaniak W.S., Zhang Y., Hagerty S., Crow M.T., Kesari P., Garcia J.G., et al. Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivo. Transl Res 2008, 152:213-224.
41. Duan G.J., Zhu J., Wan J.Y., Li X., Ge X.D., Liu L.M., et al. A synthetic MD-2 mimetic peptide attenuates lipopolysaccharide-induced inflammatory responses in vivo and in vitro. Int Immunopharmacol 2010, 10:1091-1100.
42. Gong X., Luo F.L., Zhang L., Li H.Z., Wu M.J., Li X.H., et al. Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice. Int Immunopharmacol 2010, 10:357-363.
43. Jarrar D., Kuebler J.F., Rue L.W., Matalon S., Wang P., Bland K.I., et al. Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms. Am J Physiol Lung Cell Mol Physiol 2002, 283:L799-L805.
44. Riedemann N.C., Guo R.F., Hollmann T.J., Gao H., Neff T.A., Reuben J.S., et al. Regulatory role of C5a in LPS-induced IL-6 p.oduction by neutrophils during sepsis. Faseb J 2004, 18:370-372.
45. Yoon E.K., Lee W.K., Lee J.H., Yu S.M., Hwang S.G., Kim S.J. ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. J Korean Med Sci 2007, 22:1015-1021.
46. Pan P., Cardinal J., Dhupar R., Rosengart M.R., Lotze M.T., Geller D.A., et al. Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality. J Leukoc Biol 2009, 86:625-632.
47. Song G.Y., Chung C.S., Chaudry I.H., Ayala A. MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. Am J Physiol Cell Physiol 2001, 281:C662-C669.
48. Bonnans C., Fukunaga K., Levy M.A., Levy B.D. Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am J Pathol 2006, 168:1064-1072.
49. Levy B.D., De Sanctis G.T., Devchand P.R., Kim E., Ackerman K., Schmidt B.A., et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 2002, 8:1018-1023.
50. Perretti M., Getting S.J., Solito E., Murphy P.M., Gao J.L. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol 2001, 158:1969-1973.